| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.60▼ | 2.61▼ | 2.60▼ | 2.72▼ | 2.52▲ |
| MA10 | 2.61▼ | 2.59▼ | 2.62▼ | 2.60▼ | 2.85▼ |
| MA20 | 2.59▼ | 2.62▼ | 2.65▼ | 2.53▲ | 3.09▼ |
| MA50 | 2.61▼ | 2.67▼ | 2.65▼ | 3.01▼ | 2.54▲ |
| MA100 | 2.65▼ | 2.62▼ | 2.52▲ | 2.99▼ | 4.78▼ |
| MA200 | 2.69▼ | 2.52▲ | 2.63▼ | 2.74▼ | 8.59▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.003▲ | -0.010▼ | 0.058▲ | -0.113▼ |
| RSI | 47.591▼ | 42.526▼ | 41.899▼ | 45.122▼ | 45.805▼ |
| STOCH | 63.148 | 76.726 | 32.270 | 61.901 | 9.850▼ |
| WILL %R | -60.000 | -64.286 | -75.610▼ | -58.406 | -89.218▼ |
| CCI | -102.535▼ | -0.694 | -61.279 | 24.604 | -68.584 |
|
Tuesday, March 03, 2026 05:21 AM
AD/PD™ 2026 is a leading international conference dedicated to neurodegenerative diseases, convening top medical and scientific experts to present novel findings that advance understanding of disease ...
|
|
Thursday, February 19, 2026 06:57 AM
Novartis AG (NYSE:NVS) is one of the best immunotherapy stocks to buy according to hedge funds. Novartis AG (NYSE:NVS) announced on February 13 final results from the Phase III ALIGN study, stating ...
|
|
Monday, December 08, 2025 03:50 AM
Novartis AG (NYSE:NVS) is one of the Most Undervalued Stocks to Buy Right Now. On November 24, the company announced that the US FDA approved Itvisma ® (onasemnogene abeparvovec-brve) for treating ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 03/03/26 | 2.67 | 2.67 | 2.5298 | 2.58 | 170,141 |
| 02/03/26 | 2.51 | 2.76 | 2.501 | 2.67 | 434,576 |
| 27/02/26 | 2.75 | 2.8399 | 2.64 | 2.68 | 262,091 |
| 26/02/26 | 2.91 | 2.94 | 2.72 | 2.77 | 350,748 |
| 25/02/26 | 2.80 | 3.00 | 2.70 | 2.88 | 779,300 |
| 24/02/26 | 2.39 | 2.78 | 2.381 | 2.68 | 698,917 |
| 23/02/26 | 2.41 | 2.47 | 2.35 | 2.39 | 206,813 |
| 20/02/26 | 2.36 | 2.53 | 2.36 | 2.48 | 349,000 |
| 19/02/26 | 2.41 | 2.44 | 2.36 | 2.41 | 166,200 |
| 18/02/26 | 2.39 | 2.51 | 2.35 | 2.43 | 209,300 |
|
|
||||
|
|
||||
|
|